Use of emergency contraception among female young adult cancer survivors

Female young adult cancer survivors were twice as likely to use emergency contraception than the general population. Improved contraceptive counseling is needed for young cancer survivors.

0
0
Upvote 0 Comment

Volume 109, Issue 6, Pages 1114–1120.e1

Authors:

Alexa C.O. Medica, M.D., Shaylyn S. Stark, MPH, Tracy N. Hadnott, M.D., Andrew C. Dietz, M.D., M.S.C.R., Sally A.D. Romero, Ph.D., M.P.H., Loki Natarajan, Ph.D., Elena Martinez, Ph.D., Brian W. Whitcomb, Ph.D., H. Irene Su, M.D., M.S.C.E.

Abstract:

Objective

To test whether emergency contraception use in reproductive-aged cancer survivors is higher than in the general U.S. population and evaluate factors associated with use among survivors.

Design

A retrospective cohort study compared emergency contraception use between cancer survivors in the Reproductive Window Study on ovarian function after cancer and in the general population in the 2006–2010 National Survey for Family Growth. In a cross-sectional analysis of survivors, multivariable models were used to test associations between participant characteristics and emergency contraception use.

Setting

Not applicable.

Patient(s)

A total of 616 female cancer survivors aged 18–40.

Intervention(s)

None.

Main Outcome Measure(s)

Self-reported emergency contraception use.

Result(s)

The mean age of survivors was 33.4 ± 4.7, at a mean 7.5 years since diagnosis. Breast cancer (22%), Hodgkin lymphoma (18%), and leukemia (8%) were the most common cancers. Since diagnosis, 156 (25.3%) used emergency contraception, 60% because of not otherwise using contraception. Age-adjusted prevalence of use was higher in survivors than in the general population (28.3% [95% confidence interval (CI) 24.7–31.9] vs. 12.0% [95% CI 11.1–12.9]). In multivariable analysis among survivors, nonwhite race (prevalence ratio [PR] 1.3, 95% CI 1.0–1.8), breast cancer (PR 0.6, 95% CI 0.4–1.0), partnered relationship (PR 0.6, 95% CI 0.5–0.9), and older age (age 36–40 vs. 31–35; PR 0.7, 95% CI 0.5–1.0) were associated with emergency contraception.

Conclusion(s)

Female young adult cancer survivors were significantly more likely to use emergency contraception compared with the general population. Populations including nonwhite survivors have a higher risk, suggesting differences in family planning care. Strategies to improve contraception and decrease the need for emergency contraception are needed.


Read the full text here.


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.